Use of Pre-exposure (PrEP) as COMBINATION PREVENTION to contain the spread of HIV in risk groups

Abstract

Objective: To assess how the use of Pre-exposure prophylaxis (PrEP) can contribute as a means of combined prevention against HIV infection in risk groups. Bibliographic review: Given the large number of people infected with the HIV virus in the world, it is necessary to identify the most vulnerable groups to establish more effective prevention and containment treatment methods. Thus, in addition to antiretroviral therapy and condom use, Pre-Exposure Prophylaxis (PrEP) has been shown to be a powerful tool in the fight against Human immunodeficiency virus (HIV), acting to prevent infection by the virus. PrEP is indicated for all uninfected people with a sexually active life, but mainly for the most vulnerable already identified, that is, sex workers, serodiscordant couples, injecting drug users and LGBT. It is noteworthy that it must be used in combination with antiretroviral drugs, as well as with condoms. Final considerations: Amid the effectiveness of the method that is unquestionable by the scientific community and defended by several authors who debate the subject, the drug still has a lot to face, especially with regard to accurate and wide-ranging information, something that challenges the public health policies regarding the containment of the virus via PrEP.